Tuesday, May 5, 2026

Trump Calls Kim Jong Un a ‘Nuclear Power’ Amid Talks on Rebuilding Relations

Trump acknowledges Kim Jong Un as a nuclear power and expresses willingness to rebuild relations, while maintaining denuclearization goals.

Urgent Meeting Held After North Korea’s Drone Invasion Claims: Key Takeaways for Security

North Korea claims a South Korean UAV violated its airspace, prompting South Korea to hold an emergency meeting to address tensions.

South Korea Urges UN to Strengthen Multilateralism Amid Global Instability

South Korea's Vice Minister Kang Insun discusses strengthening UN multilateralism and North Korea issues with UN officials in New York.

Tag: glucagon

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.